These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 37725224)
1. Risk Factors for Breast Cancer-Related Lymphedema: An Umbrella Review. Shen A; Qiang W; Zhang L; Bian J; Zhu F; Zhang Z; Lu Q Ann Surg Oncol; 2024 Jan; 31(1):284-302. PubMed ID: 37725224 [TBL] [Abstract][Full Text] [Related]
2. Risk factors of breast cancer-related lymphoedema: protocol of an umbrella review. Shen A; Lu Q; Zhang L; Bian J; Zhu F; Zhang Z; Qiang W BMJ Open; 2023 Apr; 13(4):e070907. PubMed ID: 37045580 [TBL] [Abstract][Full Text] [Related]
3. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies. Shen A; Lu Q; Fu X; Wei X; Zhang L; Bian J; Qiang W; Pang D Support Care Cancer; 2022 Dec; 31(1):18. PubMed ID: 36513801 [TBL] [Abstract][Full Text] [Related]
4. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study. Jia M; Pan L; Yang H; Gao J; Guo F Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882 [TBL] [Abstract][Full Text] [Related]
5. Is axillary web syndrome a risk factor for breast cancer-related lymphedema of the upper extremity? A systematic review and meta-analysis. Brunelle CL; Serig A Breast Cancer Res Treat; 2024 Dec; 208(3):471-490. PubMed ID: 39414730 [TBL] [Abstract][Full Text] [Related]
6. Time trend of breast cancer-related lymphedema according to body mass index. Ogiya A; Kimura K; Ueno T; Iwase T; Ohno S Eur J Surg Oncol; 2024 Jun; 50(6):108350. PubMed ID: 38653160 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model. Li H; Li WB; Sun ZX; Yu J; Lv PY; Li CX; Liang X; Yu Y; Zhao ZB Lymphat Res Biol; 2023 Dec; 21(6):565-573. PubMed ID: 37768813 [No Abstract] [Full Text] [Related]
8. Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: A pragmatic approach to lymphedema surveillance. Hing JX; Chua YN; Tan PT; Tan MSL; Mok CW; Seet MYL; Lin ZC; Seah CM; Lee WP; Tan SM Ann Acad Med Singap; 2024 Feb; 53(2):80-89. PubMed ID: 38920232 [TBL] [Abstract][Full Text] [Related]
9. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study. Lim SM; Han Y; Kim SI; Park HS BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884 [TBL] [Abstract][Full Text] [Related]
10. Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population. Bhimani F; Feldman S; Cavalli A; Chen Y; Obaid L; Rachofsky C; Gupta A; Pastoriza J; Johnson K; McEvoy M Ann Surg Oncol; 2024 Sep; 31(9):5937-5946. PubMed ID: 38844631 [TBL] [Abstract][Full Text] [Related]
11. Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study. Wang L; Chen H; Li Y; Wang H; Liu N; Yu M; Shang S Support Care Cancer; 2023 Apr; 31(5):278. PubMed ID: 37074508 [TBL] [Abstract][Full Text] [Related]
12. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis. Lin Y; Xu Y; Wang C; Song Y; Huang X; Zhang X; Cao X; Sun Q Breast Cancer; 2021 Nov; 28(6):1261-1272. PubMed ID: 34106427 [TBL] [Abstract][Full Text] [Related]
13. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study. Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555 [TBL] [Abstract][Full Text] [Related]
14. Assessing breast cancer-related lymphedema screening and treatment gaps in a safety-net hospital. Young S; Geary A; Zhao X; Kenzik K; Cassidy M; Newman R; Merrill AL J Surg Oncol; 2024 Aug; 130(2):204-209. PubMed ID: 38873777 [TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
16. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis. Wijaya WA; Peng J; He Y; Chen J; Cen Y Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404 [TBL] [Abstract][Full Text] [Related]
17. The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees. Jinbo K; Fujita T; Kasahara R; Jinbo R; Kisara S; Onobe J; Kimijima I; Yasuda M; Yamamoto Y Breast Cancer; 2023 Jul; 30(4):685-688. PubMed ID: 36917351 [TBL] [Abstract][Full Text] [Related]
18. Manual Lymphatic Drainage for Breast Cancer-related Lymphedema: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Lin Y; Yang Y; Zhang X; Li W; Li H; Mu D Clin Breast Cancer; 2022 Jul; 22(5):e664-e673. PubMed ID: 35370085 [TBL] [Abstract][Full Text] [Related]
19. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study. Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228 [TBL] [Abstract][Full Text] [Related]
20. Impact of risk factors, early rehabilitation and management of lymphedema associated with breast cancer: a retrospective study of breast Cancer survivors over 5 years. Tomić S; Malenković G; Mujičić E; Šljivo A; Tomić SD BMC Womens Health; 2024 Apr; 24(1):226. PubMed ID: 38582869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]